Moderator: Anna Brown, Conference Producer, Informa. Featuring: Gareth Jones, Vice President of Sales EMEA, PhenomeX. In this interview from BPI Europe in May 2023, Gareth Jones, Vice President of Sales EMEA, PhenomeX discusses accelerating biological research, using optoelectric positioning and microfluidics to scale down volumes of bioreactors, and more. Watch the full interview below.
Moderator: Anna Brown, Conference Producer, Informa. Featuring: Christian Witz, CEO, Sim Vantage. In this interview from BPI Europe in May 2023, Christian Witz, CEO, Sim Vantage discusses its use of principle simulations of bioreactors, the advantages of having digitalized processes, and more. Watch the full interview below.
Moderator: Anna Brown, Conference Producer, Informa. Featuring:Â James Wilkinson, VP Strategic Business Development, Refeyn. In this interview from BPI Europe in May 2023, James Wilkinson, VP Strategic Business Development, Refeyn discusses mass photometry in the bioprocessing community, advancements in biomolecular analysis, and more. Watch the full interview below.
Moderator: Anna Brown, Conference Producer, Informa. Featuring: Ike James, PhD, Head of Transfer Technology, Medicines Patent Pool. In this interview from BPI Europe in May 2023, Ike James, PhD, Head of Transfer Technology, Medicines Patent Pool discusses how the company strives to create access for essential medicines in low and middle income countries, prepare for potential future pandemics by developing an mRNA technology platform, and more. Watch the full interview below.
Enzene Biosciences has picked Princeton, New Jersey as the location to open its first manufacturing facility outside of India. New Jersey’s non-profit economic development organization has announced contract development manufacturing organization (CDMO) Enzene, a subsidiary of India’s Alkem Laboratories, will open a biopharmaceutical manufacturing plant on the Princeton West Innovation Campus in Hopewell. Enzene has capabilities in cell line engineering, purification process development, upstream process development, advanced analytical technologies, bioanalytical sciences, and regulatory affairs. The facility is expected to be…